<DOC>
	<DOCNO>NCT02074995</DOCNO>
	<brief_summary>Study tolerability efficacy BVS857 severe burn subject 8 week 15 week</brief_summary>
	<brief_title>Study Tolerability Efficacy BVS857 Severe Burn Subjects</brief_title>
	<detailed_description>No formal analysis perform study terminate due low enrollment issue . ( n=1 patient enrol )</detailed_description>
	<mesh_term>Burns</mesh_term>
	<criteria>Burn injury comprise 2nd degree deep partial thickness and/or 3rd degree full thickness burn , â‰¥20 % total body surface area expect need surgical intervention exceed sum age plus burn size 100 ( Baux score ) Dosing must occur within 812 day postburn Subjects must weigh least 45kgs ( group 1 dose 0.03mg/kg ) 100 kg participate study Spinal cord injury Hypoxic brain injury ( Glasgow Coma Scale ( GCS ) &lt; 8 ) screen True conductive electric burn suspect neurologic injury Uncontrolled diabetes HbA1c &gt; 10 % screening , know history hypoglycemia , History active peripheral neuropathy seizure disorder Systemic corticosteroid : &gt; 10mg/d prednisone equivalent , investigational treatment ( exclude investigational dressing ) , medication weight loss include megestrol acetate , androgens oral beta agonist</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Burn , Severe burn , Lean body mass , Cachexia , Hypermetabolism , Catabolism , Wound heal</keyword>
</DOC>